Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

(R)-(+)-Bay K 8644, Tocris Bioscience™

Catalog No. 154550
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

CaV1.x blocker; (R)-(+)-enantiomer of (±)-Bay K 8644

(R)-(+)-Bay K 8644 is a L-type Ca2+-channel blocker with negative inotropic and vasodilatatory effects in vivo. Enantiomer showing opposite effects to the racemate (±)-Bay K 8644 (Cat. No. 1544) and (S)-(-)- enantiomer (Cat. No. 1546). Also TMEM176B inhibitor. Induces IL-1β secretion and caspase-1 activation in bone marrow-derived dendritic cells in vitro and increases survival of tumor-bearing mice, both alone and in combination with immune checkpoint blockers.

Racemate and (S)-(-)-Enantiomer also available.

Chemical Identifiers

CAS 98791-67-4
Molecular Formula C16H15F3N2O4
Molecular Weight (g/mol) 356.301
InChI Key ZFLWDHHVRRZMEI-CYBMUJFWSA-N
Synonym r-+-bay k 8644, bay-k-8644 r-+-, methyl 4r-2,6-dimethyl-5-nitro-4-2-trifluoromethyl phenyl-1,4-dihydropyridine-3-carboxylate, bay-k-8644 r-+, tocris-1546, bidd:pxr0106, r-bayk8644, r-bay k8644, r-bay-k-8644, r + bay k 8644
PubChem CID 6604881
IUPAC Name methyl (4R)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate
SMILES CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC

Specifications

Quantity 50 mg
Formula Weight 356.3
Percent Purity >97%
Chemical Name or Material (R)-(+)-Bay K 8644
Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.